Enoximone

DRUG4 trials

Sponsors

Gilead Sciences, Onze Lieve Vrouwe Gasthuis, Rijnstate Hospital

Conditions

COPD ExacerbationEnoximoneHeart Failure, CongestiveMicrocirculationPhosphodiesterase InhibitorSevere Sepsis

Phase 3

ESSENTIAL-The Studies of Oral Enoximone Therapy in Advanced Heart Failure

TerminatedNCT00051285

Gilead SciencesHeart Failure, Congestive

Start: 2002-02-28End: 2005-06-30Target: 1800Updated: 2014-01-10

Enoximone Plus Extended-Release Metoprolol Succinate in Subjects With Advanced Chronic Heart Failure

TerminatedNCT00077948

Gilead SciencesHeart Failure, Congestive

Start: 2003-07-31End: 2005-06-30Target: 175Updated: 2014-01-10

Phase 4

Microcirculation Guided Therapy Versus Standard Treatment of Severe Sepsis

Onze Lieve Vrouwe GasthuisMicrocirculation, Severe Sepsis

Start: 2007-06-30Target: 80Updated: 2008-01-22

The Effects of Enoximone in Acute Exacerbation COPD

TerminatedNCT04420455

Rijnstate HospitalCOPD Exacerbation, Enoximone, Phosphodiesterase Inhibitor

Start: 2020-05-12End: 2021-12-21Updated: 2022-01-13

Related Papers

Testing a conceptual model on early opening of the microcirculation in severe sepsis and septic shock

European Journal of Anaesthesiology2014-07-1721 citations